(Q34600051)

3 August 2017

1 reference

title

Sulodexide: a renewed interest in this glycosaminoglycan (English)

1 reference

3 August 2017

D Adam Lauver

1

1 reference

3 August 2017

Benedict R Lucchesi

series ordinal

2

1 reference

3 August 2017

publication date

1 September 2006

1 reference

Cardiovascular Drug Reviews

3 August 2017

published in

1 reference

3 August 2017

volume

24

1 reference

3 August 2017

issue

3-4

1 reference

3 August 2017

page(s)

214-226

1 reference

Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

A study on the safety, efficacy, and efficiency of sulodexide compared with acenocoumarol in secondary prophylaxis in patients with deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

An overview of the structure and function of thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Prevention of recurrent deep venous thrombosis with sulodexide: the SanVal registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Induction of experimental arterial occlusive thrombi in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

The low molecular weight heparin, enoxaparin, limits infarct size at reperfusion in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

C-reactive protein activates complement in infarcted human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Heparin sequencing brings structure to the function of complex oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

N-Acetylheparin pretreatment reduces infarct size in the rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Mechanisms of myocardial reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Nephropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Complement activation by C-reactive protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

Effects of glycosaminoglycans on platelet and leucocyte function: Role of N-sulfation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00214.X

10.1111/J.1527-3466.2006.00214.X

21 January 2018

Identifiers

DOI

1 reference

release_ykjcsuoi7fh7zntce4uviwkcga

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ykjcsuoi7fh7zntce4uviwkcga

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference